A double blind, placebo‐controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression

Abstract

This pilot study failed to demonstrate a benefit for galantamine augmentation of antidepressant medication in the treatment of depression in older adults. Future studies should explore strategies for reducing dropout in such longitudinal trials and more carefully assess time to response with cholinesterase inhibitor augmentation.